.avif)
Rocket Pharmaceuticals Email Format
Biotechnology
・
201-500 employees
・
Cranbury, NJ, USA
Rocket Pharmaceuticals is a clinical-stage biotechnology company developing gene therapies to provide curative treatments for patients with rare and devastating diseases.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
firstinitiallast@rocketpharma.com
Company Overview
Industry
Biotechnology
Founded
2015
Headquarters
Cranbury, NJ, USA
Revenue
$100M-$250M
FUNDING Stage
Public
Website
Key Executives
Gaurav Shah (Chief Executive Officer), Martin Wilson (Chief Corporate Officer, General Counsel and Principal Financial Officer), Christopher Stevens (Chief Operating Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Rocket Pharmaceuticals?
Rocket Pharmaceuticals uses the firstinitiallast format, so Jane Smith would be jsmith@rocketpharma.com.
What FDA-approved gene therapy has Rocket Pharmaceuticals launched for LAD-I?
Rocket Pharmaceuticals received FDA approval for Kresladi in March 2026, making it a gene therapy for severe leukocyte adhesion deficiency type 1. Kresladi uses a lentiviral ex vivo platform and is marketed for this ultra-rare inherited immune disorder.
Which cardiovascular gene therapy program is Rocket Pharmaceuticals advancing in its pivotal Phase 2 trial in 2026?
Rocket Pharmaceuticals is advancing RP-A501, its AAV-based gene therapy for Danon disease, with the pivotal Phase 2 trial resuming in the first half of 2026. Danon disease is a rare, life-threatening cardiac condition caused by a single-gene defect.
Who co-founded Rocket Pharmaceuticals and currently serves as its CEO?
Gaurav Shah, MD, co-founded Rocket Pharmaceuticals and serves as its Chief Executive Officer. He previously led global gene therapy programs at Novartis and holds degrees from Harvard and Columbia University.
How can I find and verify contact details for Rocket Pharmaceuticals employees working in its hematology programs?
Rocket Pharmaceuticals follows the firstinitiallast@rocketpharma.com email format, so you can build and verify contacts for its hematology programs covering diseases like Fanconi anemia and pyruvate kinase deficiency using a tool like Clay to enrich and confirm those addresses.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating